Home-Based Extended Low-Dose Oral Misoprostol in Management of First-Trimester Pregnancy Loss in Low-Resource Communities: A Randomized Trial
- 26 June 2019
- journal article
- research article
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 69 (6) , 501-508
Abstract
Objective To investigate the efficacy, safety and tolerability of a home-based extended low-dose oral misoprostol for management of first-trimester pregnancy loss. Materials and Methods A randomized trial that was conducted in the Woman’s Health University Hospital and El-eman Maternity Hospital, Assiut, Egypt. One hundred and sixty patients were included. They were randomly assigned to receive four tablets of 200 μg misoprostol vaginally (max. 800 μg-hospital group) or 12 tablets orally, one every 3 h, over 2 consecutive days (max. 2400 μg-extended low-dose home group). For failed first dose, another similar second dose was given. Primary outcome measure was the percentage of patients with ‘medically completed miscarriages’ in each group (including complete miscarriages + incomplete miscarriages with successful post-miscarriage misoprostol). Results The total number of patients with ‘medically completed miscarriages’ in home group was 65/79 (82.3%), which was comparable to the hospital group (52/71 or 73.2%) (P = 0.182). However, the majority of patients in home group had significantly successful miscarriages after a single course of low-dose oral misoprostol, experienced much less heavy bleeding attacks and had less systemic side effects. Conclusion In low-resource communities, the home-based extended low-dose oral misoprostol protocol proved high efficacy, safety and tolerability in management of first-trimester pregnancy loss.Keywords
This publication has 11 references indexed in Scilit:
- FIGO's updated recommendations for misoprostol used alone in gynecology and obstetricsInternational Journal of Gynecology & Obstetrics, 2017
- Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysisScientific Reports, 2017
- Use of Misoprostol in Missed Abortion – A Double Edged Sword in Anemia Prevailing CountriesIOSR Journal of Dental and Medical Sciences, 2017
- A Comparative Study to Evaluate the Efficacy of Vaginal vs Oral Prostaglandin E 1 Analogue (Misoprostol) in Management of First Trimester Missed AbortionJournal of Clinical and Diagnostic Research, 2016
- Effectiveness of a single dose of oral misoprostol 600 μg for treatment in early pregnancy failureJournal of Obstetrics and Gynaecology, 2014
- Medical management of miscarriageThe Obstetrician & Gynaecologist, 2014
- Pharmacokinetics of repeated doses of misoprostolHuman Reproduction, 2009
- Misoprostol: Pharmacokinetic profiles, effects on the uterus and side‐effectsInternational Journal of Gynecology & Obstetrics, 2007
- A Comparison of Medical Management with Misoprostol and Surgical Management for Early Pregnancy FailureNew England Journal of Medicine, 2005
- Pharmacokinetics of different routes of administration of misoprostolHuman Reproduction, 2002